DB17679ExperimentalNucleic Acid Based Therapies
PRX-ASL is an intracellular enzyme replacement therapy designed to replace the missing or defective enzyme in patients with argininosuccinate lyase deficiency.
- Also known as
- PRX ASL
Which companies are running trials of PRX-ASL, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account